StocksMedium•11 November 2026•
1 min read
Enanta Pharmaceuticals Board Initiates Search for Successor to CEO Jay R. Luly
Key Facts
1Enanta Pharmaceuticals' Board of Directors has initiated a formal search for a successor to Dr. Jay R. Luly.
2The search for the new CEO will consider both internal and external candidates.
Enanta Pharmaceuticals' Board of Directors has initiated a formal search for a successor to Dr. Jay R. Luly. Benzinga reported that the search process will consider both internal and external candidates as part of a planned leadership succession strategy.
ENTA closed at $11.22 on November 10, 2026, after reaching a day high of $11.64 and a low of $10.98 during that session. The administrative move comes as the company seeks to ensure a stable transition for its top executive position.